Related Experiment Video
Updated: Aug 14, 2026

05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Infection and early atherosclerosis: does the evidence support causation?
1Division of Paediatric Cardiology, Children's Hospital, University Hospital Lund, Lund, Sweden. petru.liuba@pedi.lu.se
Acta Paediatrica (Oslo, Norway : 1992)
|September 29, 2005
Summary
Infectious pathogens may contribute to early atherosclerosis, the hardening of arteries, which begins in childhood. Endothelial injury from infection is a key mechanism linking pathogens to this cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Infectious Disease
- Pathogenesis Research
Background:
- Atherosclerotic coronary heart disease (CHD) begins in childhood, necessitating early intervention strategies.
- Identifying early pathogenesis and risk factors for CHD is crucial for cardiovascular healthcare.
- Emerging evidence suggests infectious pathogens play a role in atherosclerosis development.
Purpose of the Study:
- To explore the role of infectious pathogens in the pathogenesis of early atherosclerosis.
- To understand how infections interact with conventional risk factors and genetic profiles in atherosclerosis development.
Main Methods:
- Review of human studies and animal experiments investigating the link between infection and atherosclerosis.
- Analysis of potential mechanisms, including inflammatory, metabolic, autoimmune, and pathogen-specific pathways.
Main Results:
- Infectious pathogens are increasingly implicated in the development of atherosclerosis.
- Vulnerability of the arterial wall to infection is heightened by co-existing risk factors and genetic predispositions.
- The precise synergistic mechanisms between infection and cardiovascular risk factors remain under investigation.
Conclusions:
- Vascular endothelial injury, triggered by infection via multiple mechanisms, is a potential central link to early atherosclerosis.
- Understanding these infection-related pathways is vital for preventing childhood-onset cardiovascular disease.
Related Concept Videos
Inflammation
Overview
Causality in Epidemiology
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

